![Salman Al-Mahmood](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Salman Al-Mahmood
Career history of Salman Al-Mahmood
Former positions of Salman Al-Mahmood
Companies | Position | Start | End |
---|---|---|---|
Gene Signal International SA
![]() Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Director/Board Member | 22/09/2010 | - |
Chief Tech/Sci/R&D Officer | 22/09/2010 | - | |
Founder | 22/09/2010 | - |
Training of Salman Al-Mahmood
Université Nancy II | Doctorate Degree |
Statistics
International
Switzerland | 2 |
France | 2 |
Operational
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Gene Signal International SA
![]() Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Salman Al-Mahmood
- Experience